• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy

    2022-09-16 05:25:14LimingZhngLingfengXuYiWngJieyuLiuGunghongTnFengyingHungNongyueHeZhuoxunLu
    Chinese Chemical Letters 2022年8期

    Liming Zhng, Lingfeng Xu, Yi Wng, Jieyu Liu, Gunghong Tn,Fengying Hung, Nongyue He, Zhuoxun Lu,?

    a Key Laboratory of Tropical Translational Medicine of Ministry of Education & Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou 571199, China

    b State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China

    c Department of Clinical Laboratory, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo 315000, China

    ABSTRACT With an intensive understanding of the mechanism of immune system, developing a therapeutic tumor vaccine is one of the most perspective strategy of cancer immunotherapy.In this study, we report a facile approach to prepare graphene oxide (GO)-based therapeutic cancer-nanovaccine.The model antigen(ovalbumin, OVA) and adjuvant (CpG ODN), are conjugated with GO-PEI nanosheet through electrostatic interaction.The addition of PEG can improve biocompatibility and prevent nanoparticle aggregation.The prepared GO-based nanovaccine, GO-PEI-OVA-PEG-CpG, exhibits good biocompatibility and low toxicity both in vivo and in vitro. More importantly, it can efficiently induce the maturation of dendritic cells(DCs), the enhancement of antigen cross-presentation ability, and the amplification of cytokine production of immune cells.Impressively, this nanovaccine shows a remarkable therapeutic effect against preestablished B16-OVA-melanoma tumors, which can significantly inhibit tumor growth and prolong the survival time of the OVA-expressed tumor-bearing mice.Moreover, combining GO-PEI-OVA-PEG-CpG with NLG919, an IDO-1 (indoleamine-2,3-dioxygenase) inhibitor which can regulate the tumor microenvironment, displays a synergistic therapeutic effect.These findings indicate the GO-PEI-OVA-PEG-CpG nanovaccine actively induces an antigen-specific antitumor immune response and it combined with NLG919 could achieve better therapeutic outcomes.

    Keywords:Nanovaccine Graphene Oxide Adjuvant Tumor-specific antigen NLG919

    Malignant tumors are severe diseases in which some cells in the body grow rapidly and uncontrollably and spread to other parts of the body quietly.During the past century, human beings have invested lot of time and money seeking effective therapies for cancer treatment.The subsequent development of surgical treatment, radiotherapy, chemotherapy, and other methods has prolonged the survival time of tumor patients to a certain extent, but still cannot prevent tumor recurrence and transformation.Also, most antitumor drugs are costly.Therefore, it is necessary to develop some new antitumor therapies that effectively prolong patients’survival time and improve patients’quality of life while making them affordable for most people.

    Fig.1.Synthesis and characterization of GO-PEI-OVA-PEG-CpG nanovaccine.(A) Schematic illustration of the formation of GO-PEI-OVA-PEG-CpG nanovaccine.(B) Native-page of GO-PEI binding to OVA, W/W is the mass ratio of OVA to GO-PEI.(C) The hydrated particle size of GO-PEI, GO-PEI-OVA, GO-PEI-OVA-PEG and GO-PEI-OVA-PEG-CpG.(D)Agarose gel of GO-PEI-OVA-PEG binding to CpG ODN, W/W is the mass ratio of CpG ODN to GO-PEI.(E) AFM images of GO-PEI and GO-PEI-OVA-PEG-CpG.(F) Zeta potential of GO-PEI, GO-PEI-OVA-PEG and GO-PEI-OVA-PEG-CpG.(G) The photographs of GO-PEI-OVA-PEG-CpG dispersed in 10% FBS, PRMI, PBS and H2O for 30 days, respectively.

    With the in-depth study of malignant tumors, we gradually understand the cause of malignant tumors is that some cancer cells escape from the surveillance of the immune system and grow arbitrarily in the body.Therefore, to treat cancer fundamentally, it is necessary to reactive the human natural defense system, the immune system, which can recognize and kill tumor cells while not harming normal cells.Nowadays, some cancer immunotherapies have been developed which induce the tumor specific-immune response of the tumor bearer [1–6].The tumor vaccine has been one of the hot spots in immunotherapy research in recent years[7–14].Some preventive tumor vaccines have been marketed and widely used, such as the HPV vaccine (not a vaccine against tumor cells, but a virus vaccine used to eliminate tumor-inducing viruses).However, therapeutic tumor vaccines, which activate T cell-mediated antitumor immune responses in various ways, have been challenging to succeed.The weak immunogenicity of tumorassociated antigen, the low antigen loading efficiency, and an immunosuppressive tumor microenvironment are the main obstacles for developing therapeutic tumor vaccines.The arising of nanomaterials provides many new strategies for the development of tumor vaccines [15–19].These nano biomaterials can achieve high loading of antigens and adjuvants through electrostatic interactions, hydrophobic interactions, and covalent binding, and realize the enrichment of tumor-associated antigen in lymph nodes according to their special physical or chemical properties [19–21].In this study, we used graphene oxide (GO), an ideal biological material owing to its unique physiochemical properties [22,23], as a carrier to load model antigens and immune adjuvants to construct a new type of nano-tumor vaccine.The process of preparing a therapeutic vaccine based on GO-nanocomposite is shown in Fig.1A.Firstly, we prepared GO-PEI according to our previous work [24,25].Then, Ovalbumin (OVA), a model antigen, was combined to GO-PEI through electrostatic interaction because OVA is negatively charged(with a zeta-potential of ?2.13 mV) [26] and GO-PEI is positively charged (with a zeta-potential of +55.5 mV) [25].When the mass ratio of OVA to GO-PEI was 0.9:1, the OVA was hardly detected by the non-denatured polyacrylamide gel electrophoresis, indicating that OVA is almost completely adsorbed to GO-PEI (Fig.1B).Nanoparticle size was estimated by the dynamic light scattering(DLS).The measured average hydrated particle size of GO-PEI was 63 nm, while GO-PEI-OVA was 143 nm (Fig.1C).This increase in volume may be due to the accumulation of nanomaterials.Because aggregation is not good for loading drugs, we conjugated polyethylene glycol (PEG) to GO-PEI-OVA, which provides a steric barrier to effectively prevent material aggregation and increase the biocompatibility of nanomaterials [27,28].As expected, the measured hydrated particle size of GO-PEI-OVA-PEG was 98 nm, much smaller than that of GO-PEI-OVA, suggesting that PEG effectively prevents nanomaterial aggregation.It had been reported that GO-PEG-PEI has an effect similar to vaccine adjuvants [29], but this ability is not strong enough.Thus, we combined CpG oligonucleotide (ODN),evaluated as an excellent cancer vaccine adjuvant in multiple clinical trials [30,31], with GO-PEI-OVA-PEG through electrostatic interaction to achieve a better therapeutic effect.As illustrated in Fig.1D, when the mass ratio of CpG ODN to GO-PEI is 1:1.28, CpG ODN can be adsorbed entirely through agarose gel electrophoresis.Atomic force microscopy (AFM) analysis shows the height increase of GO-PEI-OVA-PEG-CpG nanovaccine compared to GO-PEI(Fig.1E).The obtained nanovaccine had a hydrodynamic diameter of 186 nm with a zeta-potential of ?5.995 mV (Fig.1F).The reduction in zeta potential is due to the binding of negatively charged OVA and nucleic acid to the positively charged GO-PEI.Moreover,to determine whether it can exist stably under physiological conditions, we investigated the stability of this nanovaccine by storing the nanoparticles in deionized water, PBS, RPMI 1640 medium, and FBS (10%) at 4°C.As shown in Fig.1G, the GO-PEI-OVA-PEG-CpG maintains good dispersibility in these solutions for 30 days, suggesting that the obtained nanovaccine is very stable under physiological conditions.

    Fig.2.Endocytosis of cells.(A) The OVA+CpG group and GO-PEI-OVA-PEG-CpG containing the same concentrations of OVA and CpG were incubated with the CD11c+ BMDCs for 12 h, and then the fluorescence intensity was measured by flow cytometry.?P < 0.05.(B) GO-PEI-OVA-PEG-CpG nanovaccine with FITC was incubated with BMDCs for 6 h, then fixed and imaged using the confocal microscope.

    Whether nanomaterials can enter cells is essential for playing their functionsin vivo.In general, phagocytic cells, such as macrophages, neutrophils, and DCs, are preferentially take up anionic nanoparticles [32], suggesting that the prepared negatively charged nanovaccine might be more easily taken up by these immune cells.To verify our hypothesis, we investigated the cellular uptake of GO-PEI-OVA-PEG-CpG nanovaccine by using Alexa Fluor 647 labelled-CpG (CpGAlexaFluor647).After incubation with GO-PEI-OVA-PEG-CpGAlexaFluor647and OVA+CpGAlexaFluor647for 12 h, respectively, the fluorescence intensities of Alexa Fluor 647 in CD11c+BMDCs (Bone marrow-derived dendritic cells) were detected.As shown in Fig.2A, the fluorescence intensity of the GO-PEI-OVA-PEG-CpGAlexaFluor647group is twice that of the OVA+CpGAlexaFluor647group.These results demonstrated that the CpG ODN, in the form of nanovaccine, is much easier to be taken up by BMDCs than free CpG ODN.In order to further confirm that the nanoparticles are indeed internalized by BMDCs, we observed the intracellular localization of the nanoparticles through a confocal microscope.BMDCs cultured with the GO-PEI-OVA-PEGCpG Alexa Fluor 647 nanovaccine were fixed, and then imaged after staining with lysosomal dyes to observe the acid lysosomes.As shown in Fig.2B, most of the nanoparticles are localized in the lysosome (demonstrated by the presence of yellow fluorescence in the merged picture).These results confirmed our hypothesis that the negatively charged GO-PEI-OVA-PEG-CpG nanovaccine could be easily taken up by DCs, and it was finally located in the lysosome.

    The biosafety of nanomedicine is also very important for clinical use [33,34].In this study, mouse fibroblast cells (BALB/3T3 cell line), macrophage-like cells (Raw264.7 cell line), mouse peritoneal macrophages, and BMDCs were used for evaluating the cytotoxicity of GO-PEI-OVA-PEG-CpG nanovaccine by CCK-8 assay.As shown in Figs.3A-D, the viabilities of all kinds of cells treated with GO-PEI and GO-PEI-OVA decrease with the increase of GO concentration, but the trend is reversed when the cells are incubated with GO-PEI-OVA-PEG and GO-PEI-OVA-PEG-CpG nanovaccine even under the incubation of high concentration.More interesting, it can be observed that the relative cell viabilities of Raw264.7, mouse peritoneal macrophages and BMDCs after incubating with GO-PEI-OVA-PEG-CpG (GO-PEI, 1.6 μg/mL) had risen to 1.63, 1.558 and 1.44, respectively, indicating that GO-PEI-OVA-PEGCpG nanovaccine can promote the proliferation of antigen presenting cell (APCs).

    If the immune system is compared to an army, DCs are undoubtedly the potent professional signal soldiers in the army.As illustrated in Fig.4A, immature DCs will transform into mature DCs after phagocytosing tumor antigens, and then mature DCs present antigen peptides through major histocompatibility complex (MHC)molecules to induce T cell activation and differentiation [35–37].To clarify whether the prepared nanovaccine can transform the status of DCs from immature into mature, we measured the expression of costimulatory molecules, which will be up-regulated during the maturation of DCs.As shown in Fig.4B, the percentage of mature BMDCs (CD11c+CD80+CD86+) remarkably increase to 43.11% after treatment with GO-PEI-OVA-PEG-CpG nanovaccine,much higher than those treated with OVA and GO-PEI-OVA-PEG,and slightly higher than those treated by the same dose of CpG(39.1%).Accordingly, the percentage of CD11c+CD40+cells increase to 75.9% for GO-PEI-OVA-PEG-CpG treatment (Fig.4C).Since the interaction between CD40 on dendritic cells and CD154 on T cells leads to T cell activation and CD40 is also thought to lead to the activation of B cells and macrophages [38], the increase in the number of CD11c+CD40+cells induced by the nanovaccine may be beneficial to improving the therapeutic effect.These results confirmed that the nanovaccine could effectively induce the maturation of DCs, and the induction effect is more robust than that of single CpG ODN.DCs present antigens to T cells through the MHC-I pathway, which is essential for activating antigen-specific cytotoxic T cells [39,40].Therefore, we tested the expression of OVA257–264(SIINFEKL) peptide (MHC-I complex on the surface of BMDCs).As illustrated in Fig.4D, the amount of OVA257–264(SIINFEKL) peptide on the surface of BMDC with treatment of GO-PEI-OVA-PEGCpG is almost twice as much as that with treatment of OVA+CpG group, indicating that GO-PEI-OVA-PEG-CpG nanovaccine can enhance antigen presentation.

    Fig.3.The relative cellular viabilities of (A) BALB/3T3 cells, (B) RAW264.7 cells, (C) macrophages, and (D) BMDCs incubated with different concentrations of GO-PEI, GO-PEIOVA, GO-PEI-OVA-PEG, and GO-PEI-OVA-PEG-CpG for 24 h.The untreated group was used as a blank control group, and the cells were treated with CpG ODN (The amount of CPG ODN is the same as the amount of CPG contained in the nanovaccine with GO-PEI concentration of 2.05 μg/mL.) was used as a positive group.

    We further detected the changes in cytokine secretion of BMDCs induced by GO-PEI-OVA-PEG-CpG nanovaccine.As shown in Figs.4E-G, after incubation with nanovaccine, the secretion of proinflammatory cytokines, including TNF-α, MCP-1 and IL-6, increases dramatically.And this tendency to stimulate increased secretion of inflammatory factors also appeared in the peritoneal macrophages and RAW264.7 cells incubated with the GO-PEI-OVAPEG-CpG nanovaccine (Fig.S1 in Supporting information).One of the main functions of IL-6 is to induce the differentiation of CD8+T cells into cytotoxic T cells, so an increase in the concentration of IL-6 in the serum may benefit for enlarging the number of cytotoxic T cells [41].Although TNF-αas a single drug, produced unsatisfactory results, it produced positive clinical results when combined with IFN-γ, IL-2 or cytotoxic drugs [42].MCP-1 induces the recruitment and activation of monocytes and macrophages, and it also stimulates the movement of T cells and natural killer cells[43].Thus, the dramatic increase in the secretion of these cytokines could help the body obtain a strong enough immune response to fight against malignant tumor cells.Moreover, the ability of GO-PEI-OVA-PEG-CpG nanovaccine to stimulate BMDCs to secrete TNF-αand MCP-1 is much stronger than that of free CpG ODN treatment alone.This is probably because CpG ODN as a component of nanovaccine is more easily absorbed by cells than free CpG ODN.The secretion of IL-10, an anti-inflammatory cytokine,somewhat unexpectedly, increased after incubation of the GO-PEIOVA-PEG-CpG or free CpG ODN (Fig.4H).This may be caused by the body’s protective mechanism.Increased regulatory cytokines can prevent excessive production of pro-inflammatory cytokines which may cause damage to normal cells [44].

    In order to explore whether the GO-PEI-OVA-PEG-CpG nanovaccine can trigger immune responsein vivo, OVA, OVA+CpG, GOPEI-OVA-PEG-CpG nanovaccine were injected into the thigh of C57 mice by intradermal injection (once per week for 2 weeks), respectively.Firstly, we measured the amount of OVA-specific cytotoxic T cells after treatment with OVA alone, OVA with adjuvant, and GOPEI-OVA-PEG-CpG nanovaccine.The results showed that almost no antigen-specific cytotoxic T cell was detected after treatment with OVA alone or OVA with adjuvant, but a large number of antigenspecific cytotoxic T cells were detected after treatment with GOPEI-OVA-PEG-CpG nanovaccine (Figs.5A and B), indicating that the mature DCs activated by the nanovaccine effectively present antigen to T cells which generate OVA257–264-specific CD8+T cells.Antigen-specific IgG plays an essential role in immunotherapy.Secondly, we tested the relative concentration of antigen-specific IgG expression in the serum of mice after each treatment.The results showed that the relative expression of antigen-specific IgG in mouse serum after GO-PEI-OVA-PEG-CpG treatment was 5 times and 2.5 times of that after OVA treatment or OVA+CpG treatment(Fig.5C).From the above results, we concluded that GO-PEI-OVAPEG-CpG nanovaccine could lead to a strong cell and humoral immune responses.

    Fig.4.GO-PEI-OVA-PEG-CpG nanovaccine efficiently activated BMDCs.(A) Schematic diagram of GO-PEI-OVA-PEG-CpG nanovaccine stimulating the maturation of BMDCs and promoting BMDCs to present antigens to T cells.(B) The percentage of CD11c+CD80+CD86+ cells was measured by the flow cytometry.(C) The percentage of CD11c+CD40+cells was measured by the flow cytometry.(D) The percentage of presenting-OVA-specific-peptide BMDCs measured by the flow cytometry.(E-H) The expression levels of TNF-α, MCP-1, IL-6, and IL-10 were secreted from BMDCs.?P < 0.05, ??P < 0.01, ???P < 0.001, ????P < 0.0001, ns: not significant.

    Thein vivoantitumor performance of GO-PEI-OVA-PEG-CpG nanovaccine was evaluated by using murine melanoma tumor model.Animal experiments in this study were approved by the Animal Ethics Committee of Hainan Medical University.Considering that the immunosuppressive microenvironment may affect the antitumor function of nano-vaccine, we planned to combine drugs that can reverse the immune microenvironment to treat tumors cooperatively.In this study, NLG919, an IDO-1 (indoleamine-2,3-dioxygenase) inhibitor, which specifically blocks IDO-trigged Tcell suppression and restores a strong T-cell response [4,45,46],was selected to synergistically improve the effects of GO-PEIOVA-PEG-CpG nanovaccine on melanoma-bearing mice.C57 mice were inoculated with B16-OVA cells and divided into 5 groups randomly with 6 individuals in each group: (1) control (PBStreated) group; (2) OVA+CpG-treated group; (3) NLG919-treated group; (4) GO-PEI-OVA-PEG-CpG-treated group; (5) GO-PEI-OVAPEG-CpG+NLG919-treated group.As shown in Fig.6A, the average tumor volume of nanovaccine-treated group is obviously lower than those of the PBS-treated group and OVA+CpG-treated group,suggesting that the GO-PEI-OVA-PEG-CpG nanovaccine could significantly inhibit tumor growth.And the smallest tumor average volume is observed in the combination therapy group, indicating that GO-PEI-OVA-PEG-CpG nanovaccine combined with the NLG919 displayed synergistic antitumor effects superior to nanovaccine-treatment alone.Moreover, the survival curve also showed the same trend.The data showed that nanovaccine therapy or combination therapy can significantly extend the survival time of B16-OVA-bearing C57 mice (more than 50% of the mice were alive within 40 days).Instead, all mice in the control (PBStreated) group and the vast majority (83.3%) of the mice treated with OVA+CpG died within 40 days (Fig.6B).The effect of NLG919 treatment alone was not good either, only 33.3% of mice survived within 40 days (Fig.6B).These results confirmed our hypothesis that the drugs which can improve the immunosuppressive tumor microenvironment could effectively improve the antitumor efficacy of GO-PEI-OVA-PEG-CpG nanovaccine.

    The earlier cell experiments confirmed that the nanovaccine has no cytotoxicity.To further study whether the GO-PEI-OVAPEG-CpG nanovaccine had a toxic and side effectsin vivo, we observed survival status and monitor the changes of body weight of C57 mice for 30 days.The mice with the treatment of nanovaccine were all alive during one month observation period without abnormal reactions.As shown in Fig.6C, there is no difference between the PBS-treated group and the GO-PEI-OVA-PEGCpG-treated group in terms of the relative weight.Tissue section images also showed that main organs were not damaged after GOPEI-OVA-PEG-CpG treatment (Fig.6D).Moreover, after treatment of nanovaccine, the biochemical indicators of mice including, alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine (CREA), and urea nitrogen (BUN), had no significant changes,proving that the GO-PEI-OVA-PEG-CpG nanovaccine has no obvious side effects on liver and kidney functions (Fig.6E).The above results proved that the GO-PEI-OVA-PEG-CpG nanovaccine has good biosafety.

    Fig.5.Activation of immune response in vivo.(A) the percentage (cells previously gated by CD3+ and CD8+) and (B) data analysis of OVA257–264-specific CD8+ T cells measured by the flow cytometry after different treatment.(C) Relative expression of IgG concentration in serum after treatment with OVA, OVA+CpG, GO-PEIOVA-PEG-CpG, respectively.?P < 0.05, ????P < 0.0001, ns: not significant.

    In summary, we developed a novel graphene oxide-based nanovaccine, GO-PEI-OVA-PEG-CpG.In vitroexperiment proved that the nanovaccine is easily taken up by BMDCs, stimulates the maturation of BMDCs, and induces BMDCs and macrophages (peritoneal macrophages and Raw264.7 cells) to secrete a large amount of proinflammatory cytokines.In vivoexperiments indicated that the GO-PEI-OVA-PEG-CpG nanovaccine can effectively induce DC maturation and activated DCs effectively present antigen to lymphocytes to generate OVA257–264-specific CD8+T cells and OVAspecific IgG.Moreover, GO-PEI-OVA-PEG-CpG nanovaccine exhibited good biosafety and evident antitumor activityin vivo, which can effectively inhibit tumor growth and prolong the survival time of mice.And the prepared vaccine could achieve a better therapeutic effect when it is combined with NLG919.

    Declaration of competing interest

    The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

    Fig.6.The in vivo therapeutic efficacy and toxicity analysis of GO-PEI-OVA-PEG-CpG nanovaccine.(A) The tumor growth curves, and (B) the survival curves of mice after different treatments.(C) The changes of relative body weight after GO-PEI-OVA-PEG-CpG nanovaccine-treatment.(D) HE staining images of main organs from mice after GOPEI-OVA-PEG-CpG nanovaccine-treatment (Scare bar: 50 μm).(E) Biochemical indexes, including ALT, AST, CREAT and BUN after GO-PEI-OVA-PEG-CpG nanovaccine-treatment.

    Acknowledgments

    We acknowledge the financial support from Basic and Applied Basic Research Program of Hainan Province (Nos.2019RC209 and 820RC646), the National Natural Science Foundation of China(No.81860037) and China Postdoctoral Science Special Foundations(Nos.2015T80488 and 2014T70459).

    Supplementary materials

    Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2022.01.071.

    一级片免费观看大全| 两人在一起打扑克的视频| 2018国产大陆天天弄谢| 在线观看舔阴道视频| 性色av一级| 午夜免费观看性视频| 国产av精品麻豆| 国产欧美日韩一区二区精品| 青春草亚洲视频在线观看| 又黄又粗又硬又大视频| 韩国精品一区二区三区| 黑人巨大精品欧美一区二区蜜桃| 欧美日本中文国产一区发布| 午夜精品久久久久久毛片777| 亚洲av电影在线观看一区二区三区| 色老头精品视频在线观看| 天天躁狠狠躁夜夜躁狠狠躁| 黄频高清免费视频| 老司机福利观看| 国产亚洲精品一区二区www | 高清av免费在线| 久久久国产一区二区| 一级片'在线观看视频| 亚洲免费av在线视频| 久久天躁狠狠躁夜夜2o2o| 国产成人精品无人区| videosex国产| 91成年电影在线观看| 俄罗斯特黄特色一大片| 国产av精品麻豆| 满18在线观看网站| 亚洲精品自拍成人| tocl精华| 亚洲欧美成人综合另类久久久| 99久久精品国产亚洲精品| 各种免费的搞黄视频| 国产成人啪精品午夜网站| 啦啦啦中文免费视频观看日本| 丰满饥渴人妻一区二区三| 亚洲视频免费观看视频| 如日韩欧美国产精品一区二区三区| 亚洲欧洲精品一区二区精品久久久| 欧美日韩av久久| 亚洲国产看品久久| 一级,二级,三级黄色视频| 法律面前人人平等表现在哪些方面 | 99国产极品粉嫩在线观看| 女人久久www免费人成看片| 久9热在线精品视频| 一级毛片女人18水好多| 老熟妇仑乱视频hdxx| www.999成人在线观看| 亚洲五月婷婷丁香| av天堂久久9| 秋霞在线观看毛片| www.999成人在线观看| 亚洲天堂av无毛| 色视频在线一区二区三区| 另类精品久久| 五月开心婷婷网| 国产极品粉嫩免费观看在线| 亚洲av成人一区二区三| 国产又爽黄色视频| 亚洲人成电影观看| 国产99久久九九免费精品| 每晚都被弄得嗷嗷叫到高潮| 亚洲一区二区三区欧美精品| 高清av免费在线| 欧美乱码精品一区二区三区| 国产xxxxx性猛交| 男女免费视频国产| 久久久精品94久久精品| 亚洲精品成人av观看孕妇| 国产精品国产av在线观看| 国产黄色免费在线视频| 精品国产乱子伦一区二区三区 | 桃花免费在线播放| 亚洲专区字幕在线| 一区福利在线观看| 久久性视频一级片| 99国产精品99久久久久| 一个人免费看片子| 色精品久久人妻99蜜桃| 久久午夜综合久久蜜桃| 成人国产一区最新在线观看| 性色av乱码一区二区三区2| 婷婷丁香在线五月| 麻豆乱淫一区二区| 国产一区二区激情短视频 | 日韩电影二区| 91国产中文字幕| 黄色a级毛片大全视频| 久久久久久久大尺度免费视频| 19禁男女啪啪无遮挡网站| 国产欧美日韩综合在线一区二区| 王馨瑶露胸无遮挡在线观看| 午夜影院在线不卡| 天天操日日干夜夜撸| 日本猛色少妇xxxxx猛交久久| 国产精品久久久久久精品电影小说| 欧美变态另类bdsm刘玥| 美女主播在线视频| 热99国产精品久久久久久7| 日韩 欧美 亚洲 中文字幕| 男女边摸边吃奶| 久久久久久久久免费视频了| 男女午夜视频在线观看| 一级片免费观看大全| 91大片在线观看| 另类精品久久| 中文字幕另类日韩欧美亚洲嫩草| 伦理电影免费视频| 亚洲av成人不卡在线观看播放网 | 亚洲精品第二区| a级片在线免费高清观看视频| 成人手机av| 日日夜夜操网爽| 新久久久久国产一级毛片| 国产成人精品久久二区二区91| 国产成人啪精品午夜网站| 国产精品国产三级国产专区5o| 国产精品二区激情视频| 99久久精品国产亚洲精品| 免费日韩欧美在线观看| 欧美黄色片欧美黄色片| 两人在一起打扑克的视频| 一边摸一边抽搐一进一出视频| 亚洲精品一二三| 别揉我奶头~嗯~啊~动态视频 | 国产精品 国内视频| 国产高清国产精品国产三级| 国产深夜福利视频在线观看| 欧美精品人与动牲交sv欧美| 丁香六月欧美| 男女无遮挡免费网站观看| 免费高清在线观看视频在线观看| 不卡av一区二区三区| 欧美黑人精品巨大| 免费在线观看黄色视频的| 亚洲欧美清纯卡通| 亚洲,欧美精品.| 后天国语完整版免费观看| 精品少妇内射三级| 午夜影院在线不卡| 亚洲一卡2卡3卡4卡5卡精品中文| 我要看黄色一级片免费的| 午夜福利乱码中文字幕| 免费在线观看黄色视频的| 夜夜骑夜夜射夜夜干| av视频免费观看在线观看| 成人手机av| 9191精品国产免费久久| 欧美亚洲日本最大视频资源| 亚洲国产看品久久| 久久中文看片网| 99国产综合亚洲精品| 久9热在线精品视频| 亚洲欧洲日产国产| 欧美日韩国产mv在线观看视频| 婷婷色av中文字幕| av欧美777| 国产一区二区三区在线臀色熟女 | 免费av中文字幕在线| 99九九在线精品视频| 妹子高潮喷水视频| 午夜福利乱码中文字幕| 一区二区三区精品91| 亚洲国产欧美网| 午夜福利乱码中文字幕| 亚洲国产av影院在线观看| www日本在线高清视频| 国产91精品成人一区二区三区 | 9191精品国产免费久久| 精品一品国产午夜福利视频| 视频区图区小说| 欧美精品啪啪一区二区三区 | 美女扒开内裤让男人捅视频| 亚洲全国av大片| 最近最新中文字幕大全免费视频| 亚洲精品久久午夜乱码| 久热这里只有精品99| 欧美人与性动交α欧美精品济南到| 人妻人人澡人人爽人人| 欧美日本中文国产一区发布| 欧美另类一区| 国产精品影院久久| 久久性视频一级片| av天堂久久9| 欧美国产精品va在线观看不卡| 嫩草影视91久久| 女性生殖器流出的白浆| 大香蕉久久成人网| 成人国产av品久久久| 精品久久蜜臀av无| 丰满少妇做爰视频| 亚洲 国产 在线| 人人妻人人爽人人添夜夜欢视频| 啪啪无遮挡十八禁网站| 国产又爽黄色视频| a级片在线免费高清观看视频| 纵有疾风起免费观看全集完整版| 久久久国产一区二区| 下体分泌物呈黄色| 国产精品香港三级国产av潘金莲| 人人妻人人澡人人爽人人夜夜| 午夜精品久久久久久毛片777| 一级毛片精品| 国产无遮挡羞羞视频在线观看| 国产精品国产av在线观看| 色精品久久人妻99蜜桃| 午夜成年电影在线免费观看| 色婷婷久久久亚洲欧美| 久久精品国产a三级三级三级| 捣出白浆h1v1| 久久久国产成人免费| 午夜免费鲁丝| 黄色 视频免费看| 老汉色av国产亚洲站长工具| 一区二区三区精品91| 成人18禁高潮啪啪吃奶动态图| 亚洲欧美日韩另类电影网站| 久热这里只有精品99| 1024视频免费在线观看| 一级毛片电影观看| 色老头精品视频在线观看| 精品人妻一区二区三区麻豆| 成人免费观看视频高清| 一区二区av电影网| 日日爽夜夜爽网站| 久久人人97超碰香蕉20202| 美女高潮到喷水免费观看| 精品久久久久久久毛片微露脸 | 久久精品人人爽人人爽视色| 亚洲人成电影免费在线| 亚洲欧美日韩高清在线视频 | 欧美 日韩 精品 国产| 久久精品熟女亚洲av麻豆精品| 欧美精品一区二区大全| 人人澡人人妻人| 国产欧美日韩一区二区三区在线| 国产有黄有色有爽视频| 欧美另类亚洲清纯唯美| 国产视频一区二区在线看| 日韩欧美一区二区三区在线观看 | 69精品国产乱码久久久| 欧美大码av| 成年人午夜在线观看视频| 久久久欧美国产精品| 两性夫妻黄色片| 久久久久久久久免费视频了| 天天躁夜夜躁狠狠躁躁| 一个人免费在线观看的高清视频 | 一级毛片女人18水好多| 亚洲全国av大片| videosex国产| 国产欧美日韩一区二区精品| 欧美激情久久久久久爽电影 | 久久久精品国产亚洲av高清涩受| 亚洲精品国产区一区二| 这个男人来自地球电影免费观看| 丝袜脚勾引网站| 国产三级黄色录像| 国产一区二区在线观看av| 十分钟在线观看高清视频www| 午夜福利在线观看吧| 日韩制服骚丝袜av| 侵犯人妻中文字幕一二三四区| 亚洲性夜色夜夜综合| 看免费av毛片| 美女高潮喷水抽搐中文字幕| 午夜成年电影在线免费观看| 久久久国产欧美日韩av| 99久久精品国产亚洲精品| 亚洲精品中文字幕在线视频| 中国美女看黄片| av不卡在线播放| 女人久久www免费人成看片| 国产日韩一区二区三区精品不卡| 男人添女人高潮全过程视频| 国产男人的电影天堂91| 国产日韩欧美在线精品| 亚洲成国产人片在线观看| 久久久久久久国产电影| 波多野结衣一区麻豆| 国产精品一区二区精品视频观看| 国产有黄有色有爽视频| 人妻人人澡人人爽人人| 99国产综合亚洲精品| 中文字幕av电影在线播放| 亚洲视频免费观看视频| 大片电影免费在线观看免费| 精品一区二区三卡| av网站在线播放免费| 国产精品影院久久| 亚洲国产av影院在线观看| 女人被躁到高潮嗷嗷叫费观| 一区二区三区精品91| 精品福利观看| 亚洲av日韩在线播放| 亚洲av片天天在线观看| 欧美日韩中文字幕国产精品一区二区三区 | 国产精品偷伦视频观看了| www日本在线高清视频| 人人妻人人澡人人爽人人夜夜| 亚洲精品久久午夜乱码| 老汉色av国产亚洲站长工具| 精品少妇久久久久久888优播| 国产av一区二区精品久久| 亚洲免费av在线视频| 自线自在国产av| 久久久国产成人免费| 国产精品一二三区在线看| 亚洲国产欧美一区二区综合| 老熟妇乱子伦视频在线观看 | 亚洲av成人一区二区三| 欧美在线黄色| 99热国产这里只有精品6| 欧美精品亚洲一区二区| 大型av网站在线播放| 亚洲自偷自拍图片 自拍| 久久女婷五月综合色啪小说| 国产日韩一区二区三区精品不卡| 一级a爱视频在线免费观看| 免费女性裸体啪啪无遮挡网站| 精品卡一卡二卡四卡免费| 国产欧美亚洲国产| 国产av国产精品国产| www.999成人在线观看| 精品第一国产精品| 国产欧美日韩一区二区三 | 女人高潮潮喷娇喘18禁视频| 精品一区二区三区四区五区乱码| 精品人妻1区二区| 国产成人一区二区三区免费视频网站| 狠狠精品人妻久久久久久综合| 国产欧美日韩一区二区精品| 中文字幕制服av| 免费观看a级毛片全部| 亚洲精品在线美女| 麻豆国产av国片精品| 999久久久精品免费观看国产| 日韩大码丰满熟妇| 国产日韩欧美视频二区| 色精品久久人妻99蜜桃| 国产日韩欧美视频二区| 成年人黄色毛片网站| 一边摸一边做爽爽视频免费| 十八禁人妻一区二区| 亚洲精品一卡2卡三卡4卡5卡 | 美国免费a级毛片| 90打野战视频偷拍视频| 人妻人人澡人人爽人人| 国产免费福利视频在线观看| 在线 av 中文字幕| 亚洲精华国产精华精| 老熟妇乱子伦视频在线观看 | 久久精品国产综合久久久| 成人亚洲精品一区在线观看| 色播在线永久视频| 精品国产一区二区三区久久久樱花| 99久久99久久久精品蜜桃| 午夜福利免费观看在线| 欧美日韩国产mv在线观看视频| 91成年电影在线观看| 中文字幕高清在线视频| 丝袜美腿诱惑在线| 不卡av一区二区三区| 亚洲欧美一区二区三区黑人| 老熟妇乱子伦视频在线观看 | 高清欧美精品videossex| 俄罗斯特黄特色一大片| www日本在线高清视频| 国产福利在线免费观看视频| a 毛片基地| 久久免费观看电影| 秋霞在线观看毛片| 成人黄色视频免费在线看| 999久久久精品免费观看国产| 香蕉国产在线看| 亚洲国产欧美日韩在线播放| 日本一区二区免费在线视频| 涩涩av久久男人的天堂| 大片电影免费在线观看免费| 国产又色又爽无遮挡免| 久久综合国产亚洲精品| 久久人妻熟女aⅴ| 免费在线观看视频国产中文字幕亚洲 | 亚洲av电影在线观看一区二区三区| 国产91精品成人一区二区三区 | 美女视频免费永久观看网站| 日韩有码中文字幕| 十八禁高潮呻吟视频| 免费不卡黄色视频| 美女中出高潮动态图| 夫妻午夜视频| 亚洲男人天堂网一区| 淫妇啪啪啪对白视频 | 精品一区在线观看国产| 久久av网站| 高潮久久久久久久久久久不卡| 啦啦啦 在线观看视频| 精品高清国产在线一区| 日韩欧美免费精品| 一边摸一边抽搐一进一出视频| 交换朋友夫妻互换小说| 国产视频一区二区在线看| 欧美成狂野欧美在线观看| 国产高清视频在线播放一区 | 美女中出高潮动态图| 欧美中文综合在线视频| 亚洲av美国av| 中文字幕高清在线视频| 亚洲精品中文字幕一二三四区 | 在线永久观看黄色视频| 精品少妇久久久久久888优播| 女人久久www免费人成看片| 一级毛片精品| 国产伦理片在线播放av一区| 欧美中文综合在线视频| avwww免费| 爱豆传媒免费全集在线观看| tube8黄色片| 首页视频小说图片口味搜索| 成年av动漫网址| 亚洲人成电影免费在线| 欧美日韩黄片免| 日韩大码丰满熟妇| 少妇 在线观看| 美女大奶头黄色视频| 色婷婷久久久亚洲欧美| 久久人妻熟女aⅴ| 亚洲自偷自拍图片 自拍| 精品国产一区二区三区久久久樱花| 丝袜美足系列| 另类亚洲欧美激情| √禁漫天堂资源中文www| 久久精品国产a三级三级三级| 精品免费久久久久久久清纯 | 亚洲av欧美aⅴ国产| av电影中文网址| 午夜福利在线免费观看网站| 亚洲精品久久午夜乱码| 99精品欧美一区二区三区四区| 9色porny在线观看| 蜜桃在线观看..| 午夜成年电影在线免费观看| 国产男人的电影天堂91| 亚洲va日本ⅴa欧美va伊人久久 | 久久天躁狠狠躁夜夜2o2o| 亚洲精品国产av成人精品| 国产欧美日韩精品亚洲av| 亚洲avbb在线观看| 午夜福利视频在线观看免费| 制服诱惑二区| 老司机影院成人| 精品久久久久久久毛片微露脸 | 老汉色∧v一级毛片| 欧美亚洲 丝袜 人妻 在线| www日本在线高清视频| 国产精品一区二区在线观看99| 亚洲国产精品一区三区| 精品视频人人做人人爽| 国产97色在线日韩免费| 韩国精品一区二区三区| 美女主播在线视频| 激情视频va一区二区三区| 欧美在线一区亚洲| 亚洲中文日韩欧美视频| 国产欧美亚洲国产| 国产一区二区 视频在线| 国产淫语在线视频| 99热网站在线观看| 亚洲精品一卡2卡三卡4卡5卡 | 亚洲av男天堂| 好男人电影高清在线观看| 免费观看a级毛片全部| 韩国高清视频一区二区三区| 纵有疾风起免费观看全集完整版| av电影中文网址| 老司机影院毛片| 午夜福利视频精品| 日本黄色日本黄色录像| 91大片在线观看| 久久精品国产亚洲av香蕉五月 | 国产一卡二卡三卡精品| 黑人猛操日本美女一级片| 波多野结衣av一区二区av| 99热国产这里只有精品6| 悠悠久久av| 国产一区二区三区av在线| 99热全是精品| 亚洲一区二区三区欧美精品| 国产精品1区2区在线观看. | 日日夜夜操网爽| 久久久久精品人妻al黑| 久久午夜综合久久蜜桃| 欧美97在线视频| 各种免费的搞黄视频| 国产日韩欧美亚洲二区| 日本撒尿小便嘘嘘汇集6| 日韩欧美国产一区二区入口| 欧美成狂野欧美在线观看| 侵犯人妻中文字幕一二三四区| 一级片免费观看大全| 在线 av 中文字幕| 99国产精品一区二区蜜桃av | 免费高清在线观看视频在线观看| 国产精品99久久99久久久不卡| 交换朋友夫妻互换小说| 欧美精品啪啪一区二区三区 | 91麻豆av在线| 一个人免费看片子| 狂野欧美激情性xxxx| av在线老鸭窝| 日韩中文字幕视频在线看片| 无遮挡黄片免费观看| 少妇的丰满在线观看| 精品亚洲成国产av| 99热网站在线观看| videos熟女内射| 国产麻豆69| 欧美+亚洲+日韩+国产| 欧美日韩一级在线毛片| 成人av一区二区三区在线看 | 国产日韩欧美视频二区| 大香蕉久久成人网| 亚洲欧美激情在线| 久久精品成人免费网站| 亚洲欧美激情在线| 亚洲av国产av综合av卡| 岛国在线观看网站| 大型av网站在线播放| 韩国高清视频一区二区三区| 99热网站在线观看| 久久毛片免费看一区二区三区| 国产免费视频播放在线视频| 高清黄色对白视频在线免费看| 性色av一级| 国产97色在线日韩免费| 亚洲第一青青草原| 国产成+人综合+亚洲专区| 视频在线观看一区二区三区| 日韩欧美国产一区二区入口| 一级毛片电影观看| 90打野战视频偷拍视频| 国产精品一区二区精品视频观看| 一进一出抽搐动态| 国产精品香港三级国产av潘金莲| 亚洲色图综合在线观看| 国产福利在线免费观看视频| 老熟妇仑乱视频hdxx| 午夜久久久在线观看| 色94色欧美一区二区| 亚洲精品成人av观看孕妇| 桃花免费在线播放| 在线精品无人区一区二区三| 亚洲一区中文字幕在线| 一进一出抽搐动态| 在线永久观看黄色视频| 午夜日韩欧美国产| 一级,二级,三级黄色视频| 亚洲av成人不卡在线观看播放网 | 亚洲,欧美精品.| 亚洲色图综合在线观看| 视频区欧美日本亚洲| 在线观看舔阴道视频| 俄罗斯特黄特色一大片| 亚洲专区国产一区二区| 国产麻豆69| 国产欧美日韩一区二区三 | 1024香蕉在线观看| 久久精品国产综合久久久| 亚洲av国产av综合av卡| 涩涩av久久男人的天堂| 黑人欧美特级aaaaaa片| 亚洲九九香蕉| 婷婷色av中文字幕| 人妻久久中文字幕网| 亚洲精品国产精品久久久不卡| 欧美日韩av久久| 国产成人一区二区三区免费视频网站| 久久久精品免费免费高清| 丝袜美足系列| 十八禁人妻一区二区| av在线老鸭窝| 脱女人内裤的视频| 欧美精品人与动牲交sv欧美| 男人舔女人的私密视频| 亚洲精品国产色婷婷电影| 俄罗斯特黄特色一大片| 超碰97精品在线观看| 人妻久久中文字幕网| 国产亚洲欧美在线一区二区| 久久国产精品影院| 亚洲免费av在线视频| 一本一本久久a久久精品综合妖精| 国产成+人综合+亚洲专区| 久久香蕉激情| 久久婷婷人人爽人人干人人爱| 久久久久久久久中文| 这个男人来自地球电影免费观看| 国产亚洲精品第一综合不卡| 高潮久久久久久久久久久不卡| 岛国在线免费视频观看| 大型黄色视频在线免费观看| 久久久久精品国产欧美久久久| 黄色视频,在线免费观看| 妹子高潮喷水视频| 成年女人毛片免费观看观看9| 久久久水蜜桃国产精品网| 久久久久国产精品人妻aⅴ院| 狂野欧美白嫩少妇大欣赏| 国产私拍福利视频在线观看| 国产成+人综合+亚洲专区| 日日干狠狠操夜夜爽|